MedTrace Logo

Comparison of the Efficacy and Safety of Risperidone Versus Risperidone Plus Low Dose of Haloperidol in the Treatment of Schizophrenia

NCT00998608 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2009-10-20

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy and safety of risperidone and risperidone plus low dose of haloperidol in the acutely schizophrenic patients.

Conditions

Interventions

DRUG

risperidone

risperidone 4mg/d

Sponsors & Collaborators

  • Kaohsiung Kai-Suan Psychiatric Hospital

    lead OTHER_GOV

Principal Investigators

  • Li-Shiu Chou, M.D. · Kai-Suan Psychiatric Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2009-07-31
Completion
2009-10-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00998608 on ClinicalTrials.gov